Pain management · 2025
Safety and efficacy of intra-arterial lidocaine administration for pain control in uterine artery embolization for cesarean scar pregnancy.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cai Tianhong, Zhang Rong, Chen Kai, Deng Ting, Zhan Tenghui
Аннотация
BACKGROUND: Uterine artery embolization (UAE) for cesarean scar pregnancy (CSP) can cause significant pain.
OBJECTIVES: To evaluate safety and efficacy of intra-arterial lidocaine during UAE for CSP.
METHODS: Retrospective study of 255 CSP patients: Control Group (184) without lidocaine; Study Group I (39) with unilateral lidocaine; Study Group II (32) with bilateral lidocaine. Outcomes included VAS pain scores and morphine usage.
RESULTS: Early postoperative VAS scores (0-2 hours) were significantly lower in study groups (p < 0.001). No differences in later VAS scores (4-24 hours), maximal VAS scores, morphine dosage, or safety indicators.
CONCLUSION: Intra-arterial lidocaine during UAE for CSP provides effective analgesia immediately post-procedure but only for the first 2-4 hours, without reducing overall opioid requirements.
OBJECTIVES: To evaluate safety and efficacy of intra-arterial lidocaine during UAE for CSP.
METHODS: Retrospective study of 255 CSP patients: Control Group (184) without lidocaine; Study Group I (39) with unilateral lidocaine; Study Group II (32) with bilateral lidocaine. Outcomes included VAS pain scores and morphine usage.
RESULTS: Early postoperative VAS scores (0-2 hours) were significantly lower in study groups (p < 0.001). No differences in later VAS scores (4-24 hours), maximal VAS scores, morphine dosage, or safety indicators.
CONCLUSION: Intra-arterial lidocaine during UAE for CSP provides effective analgesia immediately post-procedure but only for the first 2-4 hours, without reducing overall opioid requirements.